CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY

Trials shown by sponsor

Public title	Date of Registration	State
BACONAO Study	12/11/2021	Registered outdated
Nasalferon in COVID-19	12/11/2021	Registered
Nasalferon in respiratory infections in adults. Phase 3 clinical trial.	13/02/2025	Registered
CIGB 2020 in contacts and SARS-CoV-2 infection suspects	13/04/2020	Registered outdated
COURAGE-2 Study	14/03/2019	Registered outdated
ESPERANZA study	14/04/2020	Registered outdated
CIGB-258 at COVID-19	14/05/2020	Registered outdated
Safety and immunogenicity of the CIGB 2020.	14/07/2020	Registered outdated
Jusvinza in Severe Patients with Acquired Community Pneumonia	14/10/2022	Registered
Study in Hematological Malignancies	14/11/2014	Registered
Phase I with CIGB-814 in rheumatoid arthritis patients	16/02/2017	Registered
CENTAURO-6 Study	16/02/2017	Registered
Safety and therapeutic effect of administration of Jusvinza in the chronic stage of Chikungunya infection	17/11/2025	Registered
ABDALA Clinical Study - Phase III	18/03/2021	Registered
Safety and therapeutic effect of administration of Jusvinza in the post-acute stage of Chikungunya infection	19/11/2025	Registered
Jusvinza in rheumatoid arthritis	20/04/2022	Registered
THERESA	2008-10-07	Registered
FarmaPEG-I	2008-10-07	Registered
FASECU I	2008-10-16	Registered
Recombinant interferon alpha-2b in paranoid schizophrenia.	2009-02-11	Registered